Amlodipine besylate and Glaucoma - a phase IV clinical study of FDA data


Glaucoma is found among people who take Amlodipine besylate, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Amlodipine besylate and have Glaucoma. It is created by eHealthMe based on reports of 44,678 people who have side effects when taking Amlodipine besylate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On May, 22, 2022

44,678 people reported to have side effects when taking Amlodipine besylate.
Among them, 88 people (0.2%) have Glaucoma.

What is Amlodipine besylate?

Amlodipine besylate has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 48,263 Amlodipine besylate users for its effectiveness, alternative drugs and more.

What is Glaucoma?

Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 2,067 drugs and 1,445 conditions by eHealthMe.

Number of Amlodipine besylate and Glaucoma reports submitted per year:

Could Amlodipine besylate cause Glaucoma?

Time on Amlodipine besylate when people have Glaucoma *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 62.5 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 25.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 12.5 %
  • 10+ years: 0.0 %

Gender of people who have Glaucoma when taking Amlodipine besylate *:

  • female: 55.68 %
  • male: 44.32 %

Age of people who have Glaucoma when taking Amlodipine besylate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.45 %
  • 40-49: 0.0 %
  • 50-59: 10.34 %
  • 60+: 86.21 %

Common drugs people take besides Amlodipine besylate *:

  1. Vitamin D3: 16 people, 18.18%
  2. Tecfidera: 11 people, 12.50%
  3. Ampyra: 10 people, 11.36%
  4. Symbicort: 8 people, 9.09%
  5. Simvastatin: 8 people, 9.09%
  6. Travatan Z: 8 people, 9.09%
  7. Singulair: 7 people, 7.95%
  8. Hydrochlorothiazide: 7 people, 7.95%
  9. Lyrica: 7 people, 7.95%
  10. Vitamin B12: 7 people, 7.95%

Common side effects people have besides Glaucoma *:

  1. Fall: 18 people, 20.45%
  2. Cataract (clouding of the lens inside the eye): 14 people, 15.91%
  3. Weakness: 13 people, 14.77%
  4. Head Injury: 13 people, 14.77%
  5. Pain: 12 people, 13.64%
  6. Pain In Extremity: 12 people, 13.64%
  7. Gait Disturbance: 12 people, 13.64%
  8. Stress And Anxiety: 11 people, 12.50%
  9. Back Pain: 10 people, 11.36%
  10. Hypoaesthesia (reduced sense of touch or sensation): 10 people, 11.36%

Common conditions people have *:

  1. High Blood Cholesterol: 13 people, 14.77%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 12.50%
  3. Multiple Myeloma (cancer of the plasma cells): 7 people, 7.95%
  4. Muscle Spasms (muscle contraction): 5 people, 5.68%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 5.68%
  6. Hyperkalemia (damage to or disease of the kidney): 5 people, 5.68%
  7. Constipation: 4 people, 4.55%
  8. Gait Disturbance: 4 people, 4.55%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.55%
  10. Asthma: 4 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine besylate and have Glaucoma?

Check whether Glaucoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Amlodipine besylate:

Glaucoma treatments and more:

COVID vaccines that are related to Glaucoma:

How severe was Glaucoma and when was it recovered:

Expand to all the drugs that have ingredients of amlodipine besylate:

Common drugs associated with Glaucoma:

All the drugs that are associated with Glaucoma:

Common conditions associated with Glaucoma:

All the conditions that are associated with Glaucoma:

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine besylate) and Amlodipine besylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: